NOVARTIS has confirmed the US$665 million purchase of Selexys Pharmaceuticals, an Oklahoma City USA based company which specialises in inflammatory disorders.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Nov 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Nov 16